Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. GNLX
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
GNLX
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

GNLX Similar Chart Price Prediction

The price of GNLX is predicted to go up -0.14%, based on the high correlation periods with LRCX. The similarity of these two price pattern on the periods is 98.3%.

stocks logo

GNLX

stocks logo

LRCX

Down: -0.14%Similarity: 98.3%

GNLX Revenue Forecast

GNLX EPS Forecast

GNLX FAQs

What is bull’s view on GNLX?

GNLX stock has a bullish outlook due to its ongoing pivotal Phase 3 trial for Olvi-Vec in platinum-resistant ovarian cancer, with results expected in the second half of 2025. Analysts maintain strong buy ratings, with price targets ranging from $10 to $30, implying significant upside from its current price of $2.94. Positive trial outcomes could drive substantial gains, supported by FDA Fast Track designation and limited therapeutic alternatives in this space.

What is bear's view on GNLX?

GNLX stock is currently trading at $2.94, significantly below its recent price targets. Analysts have reduced their outlook, with HC Wainwright lowering the target from $32 to $30, citing ongoing clinical trials and potential long-term value. However, the stock has dropped 35.16% over six months, reflecting bearish sentiment due to limited near-term catalysts and market skepticism.

What is GNLX eps forecast for next quarter？

The market consensus for GNLX's eps in the upcoming quarter is projected to be approximately $0.22 USD.

GNLX VS S&P500

Ask Intellectia about GNLX

GNLX Analyst's Forecast

Kelsey Goodwin

Guggenheim

Strong Buy

2024-10-29

Price Target

$8

Upside

+158.9%

Guggenheim initiated coverage of Genelux with a Buy rating and $8 price target.
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free

Hot Stocks

stocks logo

APLS

Apellis Pharmaceuticals Inc

$25.15
-3.27%
stocks logo

CXT

Crane NXT Co

$55.82
-0.30%
stocks logo

HAE

Haemonetics Corp

$65.5
1.44%
stocks logo

SHC

Sotera Health Co

$12.47
1.55%
stocks logo

WRD

WeRide Inc

$19.95
0.61%
stocks logo

ALIT

Alight Inc

$6.83
0.89%
stocks logo

MHO

M/I Homes Inc

$117.13
0.18%
stocks logo

VKTX

Viking Therapeutics Inc

$28.87
0.70%
stocks logo

TCBI

Texas Capital Bancshares Inc

$79.16
0.73%
stocks logo

RARE

Ultragenyx Pharmaceutical Inc

$42.92
2.26%